Ischemic Stroke

The grounding supports vascular obstruction as the immediate cause, including thrombotic occlusion, embolic occlusion with cardiac origin, small-vessel occlusion, and atherosclerosis affecting the cerebral circulation. It also notes that some cases are cryptogenic, meaning the origin is unknown. No additional causal factors are supported in the supplied material.

Cerebral ischemia triggers brain infarction, focal neuronal injury, and cell death, with severity influenced by the duration and extent of ischemia and the location of the infarct. The literature emphasizes neuroinflammation, blood-brain barrier dysfunction, oxidative stress, matrix metalloproteinase-related injury, and immune-cell infiltration as major mechanisms that worsen tissue damage. Glial activation, cytokine signaling, and broader changes in signal transduction, neuronal plasticity, cell death, and neuroimmunomodulation are also implicated.

The supplied grounding supports atherosclerosis affecting the cerebral circulation and cardiac-origin embolism as contributors to ischemic stroke occurrence. It also indicates that systemic blood pressure can influence infarct size and neurological severity after an event, but does not establish it as a risk factor for developing the disease. No other risk factors are directly supported by the provided material.

The grounding supports treatment at the modality level as drug therapy and immune/inflammation-targeted approaches, but it does not provide specific standard regimens. The review abstracts emphasize neuroprotective and immune-modulating strategies, including targeting post-stroke inflammation, blood-brain barrier dysfunction, and immune-cell-mediated injury. No more specific standard-of-care treatment classes are supported beyond these broad categories.